Reckitt Benckiser Plc Says No Longer In Talks With Merck & Co., Inc.

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Reckitt Benckiser Group said on Wednesday it was no longer in active talks with Merck & Co about buying its consumer health business, leaving Germany’s Bayer as a leading contender for the $14 billion business. Bayer has offered to swap its animal health assets for the Merck consumer business that includes Coppertone sunscreen and pay the remainder of the price in cash, Reuters reported on Tuesday, citing people familiar with the matter. That swap may have given Bayer a leg up, since Reckitt, known for paying top dollar for attractive assets, backed down.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC